Hepatitis C virus (HCV) is a major global health problem with estimates of 170 to 300 million people chronically infected world wide. In the U.S., HCV is the leading cause of chronic liver disease and liver transplants.
Doctors are looking for better medicines to treat HCV. They want medicines that are more effective, have less toxic side effects, and are easier to take. Research leads to new medicines. The drugs for HCV being studied today work differently than the medicines that are currently available. Do you want to know more? Contact the Study Doctor and/or Study Nurse at the nearest participating clinic.
This website is designed to help people with limited treatment options find out if they are a potential candidate for new clinical trials with Merck's investigational drugs, and to locate nearest participating clinics.
We deeply appreciate your interest and willingness to consider participating in these important clinical trials
* We do not currently have any studies that are recruiting subjects. Future studies are planned and will be recruiting subjects shortly. Information about those studies will be available at this site when the studies begin recruiting subjects.
